Rob has18 years of Operations and Quality experience in the development and commercialization of novel pharmaceuticals and drug delivery systems, most recently as Director of Operations at Aradigm, where he was responsible for clinical manufacturing, engineering, and validation for Pulmaquin, the AERx Platform, and DosePro (prior to spin off to Zogenix). Rob has an MBA from the Wharton School and a BS in Biology from the University of Illinois.

Mr. Okikawa has over 30 years of experience designing and executing a variety of clinical and pre-clinical studies, including significant experience managing global pulmonary clinical studies for the US and European markets. He has held technical and managerial positions at Children’s Hospital Oakland, Nellcor, Aradigm, and MAP Phamaceuticals. Jerry has a BS in Biology from UC Davis, an MBA from St. Mary’s and is a Respiratory Therapist.

Mr. Garver has over 40 years of experience in the health care industry including positions with Ciba Pharmaceuticals (Novartis) Bristol Myers Squibb, and Fissons. Tom is one of two active founders of Map Pharmaceuticals where he served as VP Commercial Development. Tom serves on the Boards of Urac Pharma Inc. and Cytologics Inc. He has an AB degree from Drew University in Economics and an MBA from Columbia University.